KZA 0.00% 8.0¢ kazia therapeutics limited

How does GBM AGILE work?, page-59

  1. 1,152 Posts.
    lightbulb Created with Sketch. 832
    CLINICAL TRIAL APPROVAL FOR SIM0395 (PAXALISIB) ISSUED BY THENATIONAL MEDICAL PRODUCTS ADMINISTRATION
    Thank you for the Simcere link. Yes they now have trial approval for paxalisib for the treatment of glioblastoma (GBM) covering patients of new diagnosis and relapse.

    We now wait for an announcement from GCAR for details of the China GBM AGILE study arms.

    Regards.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.